Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AUTORISERET FYSIOTEPEUT TM REHAB ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   6.1% 9.3% 4.8% 10.6% 3.6% 3.1% 5.3% 5.2%   Credit score (0-100)   40 28 45 22 52 50 42 43   Credit rating   BBB BB BBB BB BBB BBB BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 453 459 412 895 856 856 856   Gross profit   355 453 459 412 895 856 0.0 0.0   EBITDA   -10.7 90.6 197 126 468 320 0.0 0.0   EBIT   -24.3 70.0 176 110 457 312 0.0 0.0   Pre-tax profit (PTP)   -81.0 63.3 172.3 108.6 456.7 308.2 0.0 0.0   Net earnings   -81.0 63.3 172.3 108.6 358.4 241.0 0.0 0.0   Pre-tax profit without non-rec. items   -81.0 63.3 172 109 457 308 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   76.1 55.5 34.9 18.3 7.0 0.0 0.0 0.0   Shareholders equity total   230 293 466 574 933 1,174 1,049 1,049   Interest-bearing liabilities   177 152 40.4 0.1 64.8 193 0.0 0.0   Balance sheet total (assets)   448 491 563 642 1,169 1,486 1,049 1,049   Net Debt   42.2 55.3 -206 -48.1 -129 40.9 -1,049 -1,049     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 453 459 412 895 856 856 856   Net sales growth   0.0% 0.0% 1.4% -10.3% 117.3% -4.4% 0.0% 0.0%   Gross profit   355 453 459 412 895 856 0.0 0.0   Gross profit growth   -3.5% 27.4% 1.4% -10.3% 117.3% -4.4% -100.0% 0.0%   Employees   0 0 0 0 0 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   448 491 563 642 1,169 1,486 1,049 1,049   Balance sheet change%   -33.7% 9.4% 14.7% 14.1% 82.1% 27.1% -29.4% 0.0%   Added value   -10.7 90.6 196.7 126.1 473.6 319.5 0.0 0.0   Added value %   0.0% 20.0% 42.8% 30.6% 52.9% 37.3% 0.0% 0.0%   Investments   20 -41 -41 -33 -23 -14 0 0   Net sales trend   0.0 0.0 1.0 -1.0 1.0 -1.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 20.0% 42.8% 30.6% 52.3% 37.3% 0.0% 0.0%   EBIT %   0.0% 15.5% 38.4% 26.6% 51.1% 36.5% 0.0% 0.0%   EBIT to gross profit (%)   -6.8% 15.5% 38.4% 26.6% 51.1% 36.5% 0.0% 0.0%   Net Earnings %   0.0% 14.0% 37.5% 26.4% 40.0% 28.2% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 18.5% 42.0% 30.4% 41.3% 29.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 14.0% 37.5% 26.4% 51.0% 36.0% 0.0% 0.0%   ROA %   -3.6% 14.9% 33.4% 18.2% 50.5% 23.5% 0.0% 0.0%   ROI %   -3.9% 16.4% 37.0% 20.3% 58.1% 26.4% 0.0% 0.0%   ROE %   -29.9% 24.2% 45.4% 20.9% 47.6% 22.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   51.3% 59.8% 82.8% 89.5% 79.8% 79.0% 100.0% 100.0%   Relative indebtedness %   0.0% 43.6% 21.1% 16.4% 26.4% 36.4% 0.0% 0.0%   Relative net indebtedness %   0.0% 22.3% -32.7% 4.7% 4.7% 18.7% -122.5% -122.5%   Net int. bear. debt to EBITDA, %   -393.0% 61.0% -105.0% -38.1% -27.6% 12.8% 0.0% 0.0%   Gearing %   77.0% 51.6% 8.7% 0.0% 7.0% 16.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   24.2% 4.1% 3.9% 4.5% 1.0% 3.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.9 1.5 2.7 7.7 3.8 3.6 0.0 0.0   Current Ratio   0.9 1.5 2.7 7.7 3.8 3.6 0.0 0.0   Cash and cash equivalent   135.0 96.3 246.8 48.1 194.0 152.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 151.9 8.0 401.2 287.2 411.7 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 66.5% 56.8% 125.7% 100.3% 130.8% 122.5% 122.5%   Net working capital   -19.9 104.1 163.8 450.5 662.2 808.1 0.0 0.0   Net working capital %   0.0% 23.0% 35.7% 109.4% 74.0% 94.4% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 856 0 0   Added value / employee   0 0 0 0 0 320 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 320 0 0   EBIT / employee   0 0 0 0 0 312 0 0   Net earnings / employee   0 0 0 0 0 241 0 0